measles, mumps, and rubella vaccine (MMR) Report issue

Active Ingredient History

  • Now
The MMR vaccine is a vaccine against measles, mumps, and rubella, abbreviated as MMR. The first dose is generally given to children around 9 months to 15 months of age, with a second dose at 15 months to 6 years of age, with at least four weeks between the doses. After two doses, 97% of people are protected against measles, 88% against mumps, and at least 97% against rubella. The vaccine is also recommended for those who do not have evidence of immunity, those with well-controlled HIV/AIDS, and within 72 hours of exposure to measles among those who are incompletely immunized. It is given by injection.   Wikipedia

More Chemistry
  • Mechanisms of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data
attenuated measles mumps rubella | measles, mumps and rubella combined vaccine, live | measles, mumps and rubella vaccine | measles, mumps, and rubella vaccine | measles, mumps, and rubella virus vaccine live | measles, mumps, and rubella virus vaccine, live | measles virus enders edmonston strain (live, attenuated) / mumps virus jeryl lynn (level b) strain (live, attenuated) / rubella virus wistar ra 27/3 strain (live, attenuated) | mmr | mmrii | mmr ii | mmr-v | mmr vaxpro | mumps vaccine | trivivac vaccine | v419


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue